These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12117691)

  • 21. Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Thornton C; Ong V; Ward J; Kennedy N; Steuer A
    Rheumatology (Oxford); 2008 Sep; 47(9):1438; author reply 1438. PubMed ID: 18617550
    [No Abstract]   [Full Text] [Related]  

  • 22. [Subcutaneous self-administration of methotrexate in rheumatoid arthritis].
    Huisman AM; Schouten JP; van Paassen HC; Wouters JM; Jacobs JW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1564-5. PubMed ID: 8765767
    [No Abstract]   [Full Text] [Related]  

  • 23. Shortening infusion times for infliximab administration.
    Buch MH; Bryer D; Lindsay S; Rees-Evans B; Fairclough A; Emery P
    Rheumatology (Oxford); 2006 Apr; 45(4):485-6. PubMed ID: 16352636
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
    Schiff MH; Sadowski P
    Rheumatol Int; 2017 Feb; 37(2):213-218. PubMed ID: 28012023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.
    Wegrzyn J; Adeleine P; Miossec P
    Ann Rheum Dis; 2004 Oct; 63(10):1232-4. PubMed ID: 15361377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis].
    Kawai S; Ochi T; Kondo H; Nishioka K; Nobuyuki N; Yoshino S
    Ryumachi; 2002 Feb; 42(1):76-9. PubMed ID: 11925910
    [No Abstract]   [Full Text] [Related]  

  • 28. Pilot study using the combination of methotrexate and thalidomide in the treatment of rheumatoid arthritis.
    Scoville CD
    Clin Exp Rheumatol; 2001; 19(3):360-1. PubMed ID: 11407104
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
    Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB
    Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721
    [No Abstract]   [Full Text] [Related]  

  • 30. Superficial Tissue Necrosis Related to Methotrexate Injection in a Patient With Rheumatoid Arthritis.
    Estrada Alarcon PV; García-Díaz S; Oña M; Corominas H
    J Clin Rheumatol; 2015 Oct; 21(7):370. PubMed ID: 26398466
    [No Abstract]   [Full Text] [Related]  

  • 31. Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate.
    Golden HE
    J Rheumatol; 1997 Dec; 24(12):2487-8. PubMed ID: 9415667
    [No Abstract]   [Full Text] [Related]  

  • 32. Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease.
    Moitra RK; Ledingham JM; Hull RG; McCrae FC; Thomas AL; Shaban R; Mackay KR
    Rheumatology (Oxford); 2005 Feb; 44(2):256-7. PubMed ID: 15637036
    [No Abstract]   [Full Text] [Related]  

  • 33. Benefit and risk of methotrexate treatment in rheumatoid arthritis.
    Rau R; Herborn G
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S83-94. PubMed ID: 15552520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
    Braun J; Kästner P; Flaxenberg P; Währisch J; Hanke P; Demary W; von Hinüber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A;
    Arthritis Rheum; 2008 Jan; 58(1):73-81. PubMed ID: 18163521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Malleson P
    N Engl J Med; 1995 Dec; 333(23):1567; author reply 1568-9. PubMed ID: 7477177
    [No Abstract]   [Full Text] [Related]  

  • 36. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.
    Klarenbeek NB; van der Kooij SM; Güler-Yüksel M; van Groenendael JH; Han KH; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Feb; 70(2):315-9. PubMed ID: 21068104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S; Rau R
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative efficacy of subcutaneous versus oral methotrexate in active rheumatoid arthritis.
    Islam MS; Haq SA; Islam MN; Azad AK; Islam MA; Barua R; Hasan MM; Mahmood M; Safiuddin M; Rahman MM; Osmany MF; Bari N; Rumki RS; Rashid FB
    Mymensingh Med J; 2013 Jul; 22(3):483-8. PubMed ID: 23982537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tofacitinib versus methotrexate in rheumatoid arthritis.
    Yuan K; Chen J; Xu A
    N Engl J Med; 2014 Sep; 371(12):1163-4. PubMed ID: 25229928
    [No Abstract]   [Full Text] [Related]  

  • 40. Tofacitinib versus methotrexate in rheumatoid arthritis.
    Sexton D
    N Engl J Med; 2014 Sep; 371(12):1163. PubMed ID: 25229927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.